Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study-Reference-Cited by-同舟云学术

Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study

Published:2019-08-03 Issue:2 Volume:23 Page:203-211
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Kanda Mitsuro,Suh Yun-Suhk,Park Do Joong,Tanaka Chie,Ahn Sang-Hoon,Kong Seong-Ho,Lee Hyuk-Joon,Kobayashi Daisuke,Fujiwara Michitaka,Shimada Hideaki,Cho BeLong,Murotani Kenta,Kim Hyung-Ho,Yang Han-Kwang,Kodera Yasuhiro^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-019-00995-z.pdf

Reference32 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388:2654–64.

3. Kanda M, Kodera Y. Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol. 2015;21:9838–52.

4. Ito M, Oshima Y, Yajima S, Suzuki T, Nanami T, Shiratori F, et al. Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer? Ann Gastroenterol Surg. 2018;2:313–8.

5. Park DJ, Seo AN, Yoon C, Ku GY, Coit DG, Strong VE, et al. Serum VEGF-A and tumor vessel VEGFR-2 levels predict survival in Caucasian but not Asian patients undergoing resection for gastric adenocarcinoma. Ann Surg Oncol. 2015;22(Suppl 3):S1508–S15151515.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Biomarkers of Gastric Preneoplasia and Cancer Lesions in Blood: A Comprehensive Review;Cancers;2024-08-29

2. MUC16 as a serum-based prognostic indicator of prometastatic gastric cancer;Scientific Reports;2024-07-02

3. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the ERK1/2 and JAK/STAT pathways;Gastric Cancer;2024-02-22

4. Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma;Heliyon;2024-01

5. Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric cancer growth viaBCL‐2‐mediated intrinsic apoptosis;International Journal of Cancer;2023-12-27